The winner of the Kentucky Derby, Medina Spirit, was treated with an ointment that included betamethasone, said its trainer, Bob Baffert.
Medina Spirit, a thoroughbred race horse, failed a post-derby drug test for the anti-inflammatory steroid betamethasone, putting the horse’s race into question.
Baffert, in a statement released by his lawyer, said the horse was treated with an ointment.
“Following the Santa Anita Derby, Medina Spirit developed dermatitis on his hind end. I had him checked out by my veterinarian who recommended the use of an anti-fungal ointment called Otomax. The veterinary recommendation was to apply this ointment daily to give the horse relief, help heal the dermatitis and prevent it from spreading,” the statement released Tuesday reads.
Betamethasone is allowed in horse racing, but Medina Spirit’s test detected 21 picograms per milliliter, which is more than double the allowed limit for a drug test.
“While we do not know definitively that this was the source of the alleged 21 picograms found in Medina Spirit’s post-race blood sample, and our investigation is continuing, I have been told by equine pharmacology experts that this could explain the test results. As such, I wanted to be forthright about this fact as soon as I learned of this information,” Baffert’s statement also said.
Baffert has since been banned from entering any of his horses at the Kentucky Derby, an annual race at the Churchill Downs track in Louisville.
Earlier, the trainer said that the horse wasn’t treated with betamethasone.
According to reports, a second blood test sample will now be administered, but that will not be available for at least four to eight weeks. If the blood sample comes back positive, Medina Spirit will lose the Kentucky Derby prize, and second-place Mandaloun will be named the winner.
Meanwhile, the $1.86 million first-place prize will be handed over to Mandaloun.
“So now even our Kentucky Derby winner, Medina Spirit, is a junky ... The whole world is laughing at us as we go to hell,” he added.